ArticleThe Journal of biological chemistry2026
Agmatine as the initiating substrate for aspartate semialdehyde-dependent bacterial spermidine biosynthesis.
Article in The Journal of biological chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Putrescine has long been considered the initiating substrate for aspartate semialdehyde-dependent bacterial spermidine biosynthesis. However, two recent studies identified a variant pathway in which agmatine serves as the preferred substrate. This variation appears to be common, but the mechanistic basis for substrate preference was unknown. Here, we investigate the aspartate semialdehyde-dependent dehydrogenases from Bacteroides fragilis and Clostridium leptum using steady-state and transient-state kinetic assays, mass spectrometry, thermal shift protein stability assays, X-ray crystallography, small-angle X-ray scattering, and computational modeling. Both enzymes exhibit dramatically enhanced catalytic efficiency with agmatine, demonstrating that these homologs function as carboxyaminopropylagmatine dehydrogenases rather than carboxyspermidine dehydrogenases. Agmatine enhances NADPH binding affinity by 34-fold, whereas putrescine has a modest effect and at concentrations less likely to be physiologically relevant. Apo crystal structures and small angle X-ray scattering analysis reveal substantial ligand-dependent conformational rearrangements involving both global domain and active-site loop motions. These structural transitions, together with thermal stability measurements and transient-state binding assays, support an induced-fit mechanism in which agmatine promotes conformational rearrangements that enhance NADPH-binding. Comparative sequence analysis of homologs and ligand docking lead us to propose an active-site recognition loop governing discrimination between agmatine, putrescine, and diaminopropane substrates. Together, these findings redefine the substrate specificity of the B. fragilis and C. leptum enzymes, establish a mechanistic model for agmatine-dependent catalysis in alternative spermidine biosynthesis, and provide a testable framework for predicting substrate specificity across this family of bacterial polyamine biosynthetic enzymes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.